Related Experiment Video
Updated: Dec 30, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma
Fu Jun1, Zheng Peng2, Yi Zhang2
1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, China.
Objective:
Although methotrexate (MTX) is commonly used for the treatment of choriocarcinoma, chemoresistance to MTX may occur in a considerable fraction of patients. Further understanding on the mechanisms of MTX resistance would help to develop more effective therapy for choriocarcinoma.
Methods:
Quantitative proteomic approach involving TMT labeling and LC-MS/MS was used to identify MTX resistance-related proteomic profiles in choriocarcinoma cell models. Pathway and process enrichment analysis were conducted to identify MTX resistance-related biological processes/molecular pathways. CCK-8 viability assay, clonogenic survival assay, and BrdU incorporation analysis were used to examine the chemosensitivity to MTX in choriocarcinoma cells.
Results:
In total, 5704 protein groups were identified, among which 4997 proteins were quantified. Bioinformatic analysis revealed that multiple biological processes/molecular pathways might be associated with MTX resistance in JEG3/JEG3/MTX cell systems. DPP4 and METTL7A were selected for further investigation. Increased expression of DPP4 or METTL7A was observed in MTX-resistant cancer cell lines and choriocarcinoma tissues. Knockdown of DPP4 or METTL7A significantly decreased cell viability, impaired clonogenesis, and increased apoptosis after MTX treatment in JEG3/MTX and JAR/MTX cells; while over-expression of DPP4 or METTL7A promoted cell viability and reduced apoptosis following exposure to MTX in JEG3, JAR and BEWO cells. Further, DPP4 and METTL7A differentially activated prosurvival signaling pathways including PI3K/AKT, ERK1/2 and STAT3, and attenuated the accumulation of reactive oxygen species (ROS) in choriocarcinoma cell lines.
Conclusions:
DPP4 and METTL7A might promote MTX resistance through activating pro-survival signaling pathways and attenuating the accumulation of ROS in choriocarcinoma cells. Targeting DPP4 and METTL7A might be useful to sensitize choriocarcinoma cells to MTX-based chemotherapy.
Insights
Methotrexate resistance in choriocarcinoma involves DPP4 and METTL7A proteins. Targeting these proteins may enhance chemotherapy effectiveness by overcoming resistance and reducing cell survival.
Area of Science:
- Oncology
- Molecular Biology
- Proteomics
Background:
- Methotrexate (MTX) is a key chemotherapy for choriocarcinoma.
- Chemoresistance to MTX is a significant clinical challenge.
- Understanding MTX resistance mechanisms is crucial for improving treatment outcomes.
Purpose of the Study:
- To identify proteomic profiles associated with MTX resistance in choriocarcinoma.
- To elucidate the molecular mechanisms underlying MTX resistance.
- To explore potential therapeutic targets for overcoming MTX resistance.
Main Methods:
- Quantitative proteomics using TMT labeling and LC-MS/MS.
- Bioinformatic analysis of proteomic data for pathway enrichment.
- In vitro chemosensitivity assays (CCK-8, clonogenic survival, BrdU incorporation).
Main Results:
- Identified 5704 protein groups, quantifying 4997.
- DPP4 and METTL7A expression correlated with MTX resistance in cell lines and tissues.
- DPP4/METTL7A modulated cell viability, apoptosis, and activated pro-survival pathways (PI3K/AKT, ERK1/2, STAT3) while reducing ROS.
Conclusions:
- DPP4 and METTL7A promote MTX resistance by activating pro-survival pathways and reducing ROS.
- Targeting DPP4 and METTL7A shows potential for sensitizing choriocarcinoma to MTX.
- These findings offer novel therapeutic strategies for MTX-resistant choriocarcinoma.
More Related Videos
06:43A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
Published on: August 31, 2013
08:11Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Published on: August 7, 2021